Compare EARN & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EARN | SWKH |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Diversified Financial Services |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 200.3M | 205.9M |
| IPO Year | 2013 | 1999 |
| Metric | EARN | SWKH |
|---|---|---|
| Price | $5.30 | $17.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $5.88 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 399.2K | 7.2K |
| Earning Date | 03-11-2026 | 03-18-2026 |
| Dividend Yield | ★ 17.58% | N/A |
| EPS Growth | N/A | ★ 120.89 |
| EPS | N/A | ★ 1.85 |
| Revenue | $35,893,000.00 | ★ $40,149,000.00 |
| Revenue This Year | $8.43 | $52.93 |
| Revenue Next Year | $17.28 | N/A |
| P/E Ratio | ★ N/A | $9.45 |
| Revenue Growth | 43.30 | ★ 62.38 |
| 52 Week Low | $4.33 | $13.17 |
| 52 Week High | $6.70 | $20.49 |
| Indicator | EARN | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 56.50 |
| Support Level | $5.55 | $17.22 |
| Resistance Level | $5.72 | $17.60 |
| Average True Range (ATR) | 0.11 | 0.17 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 0.00 | 81.13 |
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.